HBM Partners — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
Symbiomix TherapeuticsApr 2016
BiotechNewark, US
Robert Jacks(Executive Officer)Joseph Amprey(Executive Officer)in
BoardRishi Gupta(Director)inKlaus Veitinger(Director)inThomas Beck(Director)Ben Auspitz(Director)
Co-investorsF-Prime CapitalHBM Healthcare InvestmentsOrbiMed
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.